US equities |
NVDA $233.95 ▲+1.34% MU $1,074.89 ▼-2.05% TSLA $370.59 ▲+4.65% SPCX $158.96 ▲+7.35% SNDK $1,719.99 ▼-3.79% AMD $633.91 ▲+2.95% STX $848.99 ▼-10.21% INTC $119.33 ▼-0.56%
FinancialContent

Johnson & Johnson (NY:JNJ)

256.03 -2.63 (-1.02%)
Official Closing Price Updated: 7:00 PM EDT, Oct 2, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Johnson & Johnson

< Previous 1 2
...
5 6 7 8 9 10 11 12 13
...
99 100 Next >
News headline image
2 Wide-Moat Dividend Stocks to Buy and Hold Forever ↗
Their dividends are about as safe as they come. 
Via The Motley Fool
News headline image
Why Johnson & Johnson, Altria, Verizon, and Other Safe Dividend Stocks Climbed Today ↗
Low-risk stocks are back in vogue. 
Via The Motley Fool
Topics Artificial Intelligence Economy
Uncover the latest developments among dow jones stocks in today's session. ↗
Via Chartmill
Exploring the top movers within the dow jones index during today's session. ↗
Via Chartmill
News headline image
SpaceX Stock Is All Over the Place. 3 Dividend Stocks to Buy Instead That Will Let You Sleep Well at Night ↗
Long-term investors should skip the SpaceX roller coaster, and pivot toward these three Dividend Kings instead. 
Via The Motley Fool
Topics Initial Public Offering
Which dow jones stocks are moving on Monday? ↗
Via Chartmill
Top dow jones movers in Monday's session ↗
Via Chartmill
News headline image
5 Dividend Stocks to Buy and Hold Forever ↗
Get rich slowly. How? Hold these stocks and reinvest the dividends they pay. 
Via The Motley Fool
Topics Intellectual Property
News headline image
1 Vanguard Index Fund Could Turn $450 Per Month Into a $905,200 Portfolio That Pays $16,400 in Annual Dividend Income ↗
Young adults with median earnings can build sizable portfolios that pay a hefty amount of passive income by retirement. 
Via The Motley Fool
Topics ETFs Retirement
News headline image
If I Had to Start Over With $1,000 in Stocks Today, Here's Exactly What I'd Buy ↗
These well-established companies are on track to deliver more growth. 
Via The Motley Fool
Topics Intellectual Property
News headline image
Where to Put $1,000 When the Market Is This Uncertain ↗
In an unstable market, these three companies offer investors a chance to own durable consumer businesses that generate steady growth regardless of economic headlines. 
Via The Motley Fool
Topics Economy World Trade
News headline image
Smart Money Is Fleeing Tech for Johnson & Johnson Ahead of the Next Market Storm ↗
Bear markets are a part of investing life, but you can prepare for them ahead of time. 
Via The Motley Fool
Topics Economy
Stay informed with the top movers within the dow jones index on Thursday. ↗
Via Chartmill
Uncover the latest developments among dow jones stocks in today's session. ↗
Via Chartmill
News headline image
3 Stocks Doing the Heavy Lifting in Healthcare’s Rebound ↗
Led by Eli Lilly’s GLP-1 success, Humana’s expanding margins, and DexCom’s medtech growth, the healthcare sector is staging a major market rebound. 
Via MarketBeat
Explore the top gainers and losers within the dow jones index in today's session. ↗
Via Chartmill
News headline image
Billionaire Ken Griffin Sold Amazon and Nvidia but Quietly Loaded Up on This Healthcare Giant ↗
It could be a great move by the billionaire hedge fund manager. 
Via The Motley Fool
Topics Artificial Intelligence World Trade
Discover which dow jones stocks are making waves on Monday. ↗
Via Chartmill
News headline image
Johnson & Johnson Invests more than $1 Billion to Strengthen U.S. Vision Manufacturing in Jacksonville, Florida
From Johnson & Johnson
Via Business Wire
Stay informed with the top movers within the dow jones index on Friday. ↗
Via Chartmill
News headline image
Johnson & Johnson Just Paid $1 Billion for a Technology That Could Crack One of Cancer's Most "Undruggable" Targets. Why That's Very Good News for Investors. ↗
Medical science's capabilities are catching up with what it knows about the genomics of disease. J&J just made sure it's better equipped to utilize the industry's newest capabilities. 
Via The Motley Fool
News headline image
AbbVie Reports Promising New Clinical Updates. Here's What It Means for the Company's Dividend. ↗
New cancer therapies may help fund dividend growth. 
Via The Motley Fool
Topics Intellectual Property
News headline image
Parabilis Soared 58% in the Biggest Biotech IPO on Record. Is It Too Late to Buy the Stock? ↗
It's important to consider your comfort with risk before diving in. 
Via The Motley Fool
Topics Initial Public Offering
Explore the top gainers and losers within the dow jones index in today's session. ↗
Via Chartmill
News headline image
Johnson & Johnson Hits Target With IMAAVY In Rare Blood Disorder ↗
Johnson & Johnson reports Phase 2/3 data showing IMAAVY improved hemoglobin levels in wAIHA patients and secured FDA Priority Review. 
Via Benzinga
News headline image
Johnson & Johnson Expands U.S. Availability of TECNIS PureSee IOL, an Advanced Lens Option for Cataract Surgeons and Patients
From Johnson & Johnson
Via Business Wire
Which dow jones stocks are moving on Wednesday? ↗
Via Chartmill
Stay informed with the top movers within the dow jones index on Wednesday. ↗
Via Chartmill
Tuesday's session: top gainers and losers in the dow jones index ↗
Via Chartmill
Stay informed with the top movers within the dow jones index on Tuesday. ↗
Via Chartmill
< Previous 1 2
...
5 6 7 8 9 10 11 12 13
...
99 100 Next >